Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss

Roche’s Alzheimer’s drug has cleared brain plaques in patients within 28 weeks, according to the report. The treatment now faces a larger test in 2028 to determine whether removing the plaques can also slow memory loss, a key measure of its potential clinical benefit.